Current Roles

Employees:
211
Revenue:
$19.5M
About
Entrada Therapeuticsᅢᄁ¬ツᆲ¬トᄁ mission is to treat devastating diseases by developing intracellular biologics. Using its proprietary EEVᅢᄁ¬ダᅡᄁ technology, Entrada is creating a diverse pipeline of enzyme, oligonucleotide, protein and peptide programs to efficiently engage intracellular disease targets across multiple therapeutic areas. The Companyᅢᄁ¬ツᆲ¬トᄁs novel approach addresses current challenges associated with both large and small molecule therapeutics and represents a fundamental advancement in the field of intracellular biologics. Entrada, a privately-held company, raised $59 million in a Series A financing in December 2018. The financing was co-led by 5AM Ventures and MPM Capital, along with Roche Venture Fund, MRL Ventures Fund and Agent Capital. For more information, please visit www.entradatx.com.
Entrada Therapeutics Address
6 Tide Street
Boston, MA
United States

Past Companies

Entrada TherapeuticsVice President

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.